To isolate the direct effects of EZH2 and KMT2D mutations, we utilized the patient-derived lymphoma cell line OCI-Ly7, which carry WT alleles of all the main epigenetic regulators that are known to be recurrently mutated in DLBCL [20,21,37]. Here, EZH2 is linked to lymphoma.